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SUMMARY 
 
The electrical activity of the heart, measured by application of surface body electrodes 
and recorded as an electrocardiogram, is the result of a finely tuned balance of ion movement 
(K+, Na+, Ca2+). The ionic currents collectively constitute the cardiac action potential created 
in the cell membrane and spreading throughout the different regions of the heart. Any 
disturbance of the ionic currents underlying the cardiac action potential can give rise to heart 
failure. The cardiac action potential is composed of five different phases: An initial fast 
depolarization, a partial repolarization or “notch”, a plateau, a full repolarization and finally a 
resting phase. Potassium channels are involved in the stabilization of the resting membrane 
potential of the cardiomyocytes but they are also the major component of the repolarization 
phase. 
Two repolarizing potassium currents have been identified: a fast (IKr) and a slower 
one (IKs). Impairment of either current gives rise to prolongation of the action potential 
duration and thus may induce the so-called Long QT Syndrome. KCNH2 is the molecular 
component of the IKr current whereas the association of the KCNQ1 and KCNE1 gene 
products (Kv7.1 and KCNE1 proteins) encode for the IKs current. KCNE1 is a β-subunit that 
associates with the Kv7.1 channel and changes its electrical properties. Mutations in the 
KCNQ1 gene are the most common cause of congenital Long QT Syndrome; specifically it 
causes the Long QT Syndrome 1. The repolarization abnormalities induced by “loss of 
function” Kv7.1 mutations increase the risk of polymorphic ventricular arrhythmias. These 
cardiac arrhythmias, typically in the form of torsades de pointes, may underlie ventricular 
fibrillation, recurrent syncope, and sudden death. To date, nearly 300 Kv7.1 mutations have 
been identified. About 100 of these mutations are located in the N- or the C-terminal parts of 
the channel. 
The aim of the present work was to gain a better understanding of the Kv7.1 channel 
protein function. 
In the first study we identified a Kv7.1 missense mutation in a German family with 
Long QT Syndrome. The mutation is located in the C-terminus of the Kv7.1 channel protein 
in a calmodulin binding domain, where the methionine (M) at position 520 is replaced by an 
arginine (R). Our results show that although Kv7.1/calmodulin interaction is not impaired by 
the M520R mutation, the mutated channels are retained in the ER. The amount of channels 
available in the plasma membrane is then reduced, leading to an impaired repolarization 
current and in consequence a prolongation of the action potential. 
In the second study we identified FHL2 (Four and a Half LIM protein 2), a heart 
specific scaffolding protein, as an interaction partner of the Kv7.1 channel. Though Kv7.1 or 
IKs currents did not appear to be directly affected by FHL2, we demonstrated that FHL2 is 
involved in the rescue of some disease associated KCNE1 mutants (D76N and S74L). Finally 
our data suggest that the MAP kinase 3 (MAPK3 or ERK1/2) contributes to the regulation of 
the Kv7.1 channel, which displays a consensus site in the N-terminus for this kinase. 
Our study, with the support of others, tends to demonstrate that the Kv7.1 channel 
forms a macromolecular signaling complex with its interactions partners in order to allow a 
fast response to external signals. 
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I INTRODUCTION 
Potassium channels (K+ channels) constitute a large family of pore forming proteins 
highly selective for K+ ions. They are present in virtually all cells and have a vital role, as 
demonstrated by the genetic diseases induced by their malfunction (e.g. heart failure, 
epilepsy, renal salt loss, diabetes) (Ashcroft, 2006). In this introduction, I will briefly explain 
the function of the heart. I will then describe the cardiac action potential (AP), which results 
from the concerted action of different currents, and how the cardiac AP is impaired in the so-
called Long QT Syndrome. It will be followed by an overview of the voltage-gated K+ 
channels that are vital in shaping the cardiac AP, with an emphasis on the Kv7.1 channel. I 
will then finish by briefly reviewing the intracellular regulation of Kv7.1 channels in the 
heart. 
A - The heart 
1) Structure and function 
The heart is a specialized muscle that circulates the blood and makes it flow to the 
lungs and throughout the entire body. The circulation is pulsed as the heart is beating at 
around 70 beats per minute and pumping around half a litre of blood every minute. 
The heart consists of four chambers: two atria (upper chambers) and two ventricles 
(lower chambers) (Figure 1). The deoxygenated blood arrives from the peripheral organs by 
the superior and inferior vena cava into the right atrium; it is pumped out into the right 
ventricle and carried by the pulmonary arteries to the lungs to be oxygenated. The 
oxygenated blood exits the lungs through the pulmonary veins, goes into the left atria, is 
pumped out into the left ventricle and finally exits the heart via the aorta to reach the 
peripheral organs. 
 
 
 
Figure 1: Diagram of the human heart. The deoxygenated blood comes from the peripheral organs via the 
superior and inferior vena cava. It is pumped in the right atrium and then the right ventricle before reaching the lungs. The 
oxygenated blood, coming from the lungs, goes through the left atrium and then the left ventricle where it is pumped out to 
be distributed to the peripheral organs. 
(From http://commons.wikimedia.org/wiki/Image:Diagram_of_the_human_heart_%28cropped%29.svg) 
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The electrical activity of the heart can be recorded by the application of electrodes on 
the surface of the body; such a recording is called an electrocardiogram (ECG). In the late 
1800’s the electrical activity produced by frog hearts could be recorded by direct application 
of electrodes on the organ. In 1893, Willem Einthoven introduced the term electrocardiogram 
at a medical meeting and in 1901 he improved the electrodes’ sensitivity by using a string 
galvanometer which allowed surface body recordings. The ECG is nowadays very commonly 
used in medicine as it is a rapid and non-invasive way of accessing the heart’s electrical 
activity. Einthoven was rewarded the Nobel Price in Medicine in 1924 for his discovery 
(Einthoven W, 1925). 
The electrical activity of the heart on an ECG is represented by upward and 
downward oriented waves (P, Q, R, S and T). The starting point of the electrical signal 
responsible for the heart’s contraction is the sinoatrial node (SA node); it is the heart’s natural 
pacemaker (Figure 2). The pacemaker cells contract spontaneously, i.e. they produce an 
electrical signal without the help of an external trigger. They generate electrical impulses 
about 70 times per minute which spread to the entire heart. 
 
 
 
Figure 2: Conductive system of the heart. The electrical signal is initiated in the SA node (Sino-Atrial node); it 
depolarizes the atria; it then reaches the AV node (Atrio-Ventricular node), spreads to the Bundle of His, and then to the left 
and the right Bundle Branches where it finally depolarizes the ventricles. 
(From http://www.nottingham.ac.uk/nursing/practice/resources/cardiology/function/conduction.php) 
 
The electrical signal spreads from the SA node to the atria, where it induces their 
contraction and generates a P wave on the ECG (Figure 3). It, subsequently, reaches the 
atrioventricular node (AV node), the Bundle of His and spreads out in the left and the right 
Bundle Branches, as well as in the Purkinje fibres where it induces the contraction of the 
ventricles (QRS complex on the ECG). Finally, the ventricles relax and generate a T wave on 
the ECG. 
It takes about 800 ms for the heart to complete one cycle of contraction. During this 
cycle the entire heart rests for about half the time. 
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Figure 3: Schematic of a surface ECG recorded signal. The P wave, QRS complex and T wave characteristics 
are indicated. The time between two successive T waves is approximately 800 ms corresponding to 75 T-T intervals per 
minute. The time between P and T is approximately half the time between two successive Ts (Nerbonne & Kass, 2005). 
 
2) Currents and ion channels 
The waves on an ECG represent electrical currents produced by the cardiac cells 
(cardiomyocytes). The cardiomyocytes are coupled electrically and chemically to each other 
by the presence of gap junctions in their plasma membrane. The gap junctions are channel 
proteins that connect the cytoplasm of two adjacent cells. They let small molecules (ions) 
travel between the cells and, in the case of the heart, allow it to contract in a synchronized 
manner. The electrical currents produced by the cardiomyocytes are collectively called the 
action potential (AP). The AP shape is different in the various parts of the heart; the shape 
depends on the relative expression (i.e. presence or absence as well as abundance) of ion 
channels (K+, Na+, Ca2+) and transporters in the cells. Two APs are commonly used in 
describing cardiac function: the ventricular AP and the atrial AP. 
The ventricular AP produced by the cardiomyocyte can be divided into five phases 
(Figure 4). Each phase is the result of the relative activation of ion channels (Nattel et al., 
2007;Saenen & Vrints, 2008). The first phase (phase 0) corresponds to a fast depolarization 
of the cell; i.e. the membrane potential of the cell, which is around -80 mV at rest (close to 
the equilibrium potential of K+), becomes positive. It is due to the activation of voltage-gated 
Na+ channels, which produce an inward current (Na+ ions entering the cell). Subsequently, 
the membrane potential of the cardiomyocyte repolarizes partially (the membrane potential 
becomes slightly more negative) and creates a “notch” (phase 1). This “notch” is the result of 
the inactivation of the voltage-gated Na+ channel (non-conductive state under continuous 
stimulation) and the activation of voltage-gated outward K+ currents, called Ito. The cell 
enters then a plateau phase (phase 2) which correspond to a balance between inward and 
outward currents. This phase 2 is the result of, first, the activation of L-type voltage-gated 
Ca2+ channels that have been activated by the depolarization of the cell and, second, of the 
activation of Ito outward current. The cardiomyocyte enters next a full repolarization phase 
(phase 3), due to the inactivation of the L-type voltage-gated Ca2+ channels and to the 
opening of the delayed, outwardly rectified voltage-gated K+ channels (IKr and IKs). Finally, 
phase 4 is composed by IK1 and IK,ATP currents which set the resting membrane potential of 
the cardiomyocyte. 
The atrial AP is divided in five similar phases as in the ventricle, involving the same 
currents and ion channels. However, the plateau phase of the atrial AP occurs at less positive 
potentials and the overall AP duration is shorter. This shortening is due to the presence of 
Kv1.5 channels in the atrial cells. The Kv1.5 channels produces a constant outward current 
throughout the duration of the AP, leading to less positive and shorter AP. Also the IK,Ach 
current, absent in the ventricular myocytes, contributes to a general shortening of the atrial 
AP. 
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                             Atrial AP                        Ventricular AP   
 
Figure 4: Ionic currents underlying the atrial and the ventricular APs. The currents, the pore forming α- and, 
the accessory β-subunits of the ion channels, and the genes coding for the proteins involved in the atrial (left) and ventricular 
(right) APs are shown. The AP is divided in 5 phases: Phase 0, fast depolarization (opening of Na+ channels); Phase 2, 
plateau phase (activation of both Ca2+ and K+ channels); Phase 3, repolarization (inactivation of Ca2+ channels and activation 
of K+ channels); and Phase 4, resting membrane potential. The red boxes highlight the current, the genes and the α- and β- 
subunits discussed in this thesis (Ravens & Cerbai, 2008). 
 
The balance between the different currents is critical for the proper function of the 
heart. When an imbalance occurs it can give rise to life threatening cardiac arrhythmias. 
Among those arrhythmias is the Long QT Syndrome (LQTS). It is a disorder characterized by 
a prolongation of the repolarisation phase of the ventricles (QT interval on the ECG, see 
Figure 3). This alters the electrical stability of the heart and leads to an increase risk of 
ventricular arrhythmias. These cardiac arrhythmias may underlie ventricular fibrillation, 
recurrent syncope (fainting) and sudden death. 
 
3) The Long QT Syndrome (LQTS) 
The first case of prolonged QT interval on an ECG was reported by Anton Jervell and 
Fred Lange-Nielsen in 1957 (Jervell A & Lange-Nielsen F, 1957). They have studied a 
family (2 adults and 6 children) in which 4 deaf-mute children experienced episodes of 
syncope; three of them died suddenly while playing. On the other hand, both parents and the 
remaining 2 children were healthy (no prolongation of the QT interval) and had normal 
hearing. Later, Romano and co-workers (Romano C et al., 1963) and Ward (Ward OC, 1964) 
identified an almost identical disorder but without deafness. As it was suspected that both 
disorders were genetically linked, they were joined under the name of “Long QT Syndrome”. 
Due to the increasing amount of patients with a borderline QT interval, the Long QT 
Syndrome is not only characterized by a prolongation of the QT interval anymore. Several 
criteria are taken into account to diagnose a patient with Long QT Syndrome (Table 1). After 
examination, patients are categorized in low, intermediate or high probability of LQTS. 
However, this LQTS diagnostic criteria table is not very accurate (Hofman et al., 
2007;Rossenbacker & Priori, 2007). Only few patients with genetically mapped LQTS could 
be identified with the score table. The table was used optimally when the patients with a 
β-Subunit 
KCNE1 
KCNE2 
Gene 
KCNE1 
MiRP1 
SUR2A ABCC9 
KChIP2 KCNIP2 
Navβ4 SCN4B 
Cavβ2b CACNB2b 
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score ≥2 were considered affected by the LQTS. For that reason, genetic analysis is the most 
efficient method to identify carriers of LQTS. However, this is an expensive method to 
diagnose people and it should be restricted to the first degree relatives of LQTS patients 
(Rossenbacker & Priori, 2007). 
 
 Points 
Electrocardiographic findingsa  
QTcb  
 >480 ms 3 
 460-470 ms 2 
 450 (male) ms 1 
Torsade de pointesc 2 
T wave alternans 1 
Notched T wave in 3 leads 1 
Low heart rate for aged 0.5 
  
Clinical history  
Syncopec  
 With stress 2 
 Without stress 1 
Congenital deafness 0.5 
  
Family historye  
A. Family members with definite LQTS 1 
B. Unexplained sudden cardiac death below age 30 amongst 
    immediate family members 
0.5 
Score ≤ 1 point = low probability of LQTS; 2-3 points = intermediate probability of LQTS; 
3-5 points = high probability of LQTS. 
a In the absence of medications or disorders known to affect these electrocardiographic 
features. 
b QTc calculated by Bazett’s formula where QTc=QT/√(R-R). 
c Mutually exclusive. 
d Resting heart rate below 2nd percentile for age. 
e The same family member cannot be counted in A and B. 
 
Table 1: Diagnostic criteria for Long QT Syndrome (Schwartz et al., 1993). 
 
Genetic screening of families with LQTS has allowed the identification of 11 loci, and 
subsequently 11 genes, responsible for this disease. Each gene is then associated with a type 
of LQTS (LQTS1-11). As it is of interest for this dissertation, I will only discuss in details the 
LQTS1 and 5, which are due to direct impairment of the IKs current (Kv7.1 channel and 
accessory subunit KCNE1, respectively). I will also briefly mention LQTS involving 
mutations in adaptor proteins, which impair ion channels function. The recent review by 
Saenen and Vrints (Saenen & Vrints, 2008) makes an inventory of all LQTS. 
a) The Long QT Syndrome type 1 
The Long QT Syndrome type 1 (LQTS1) results from the mutation of the KCNQ1 
gene which is located on the chromosome 11p15.5. This gene encodes a delayed rectifier 
voltage-dependant K+ channel (Kv7.1) which is the pore forming subunit of the slowly 
activating delayed rectifier IKs current (Noble & Tsien, 1968), involved in the repolarization 
of the ventricles. Kv7.1 was first partially cloned by Wang and colleagues (a part of the N-
terminus was missing) (Wang et al., 1996) before two groups cloned in parallel the full 
length clone (Barhanin et al., 1996;Sanguinetti et al., 1996). To date nearly 300 “loss of 
function” mutations have been identified (http://www.fsm.it/cardmoc/) and they account for 
more than 40% of the LQTS patients (Tester et al., 2005). The Kv7.1 mutations can lead to 
the autosomal recessive Jervell and Lange-Nielsen syndrome (associated with deafness) or 
the autosomal dominant Romano-Ward syndrome. The LQTS1 patients experience syncope 
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or cardiac arrest mostly during exertion or emotional stress. Exercise and stress stimulate the 
sympathetic nervous system which increases the IKs current in order to shorten the AP 
duration and thus increase the heart rate. The increase in IKs current due to sympathetic 
stimulation is impaired in some mutated Kv7.1 channels and lead to ventricular arrhythmia 
(Terrenoire et al., 2005). 
b) The Long QT Syndrome type 5 
The Long QT Syndrome type 5 has been first described by Splawski and colleagues in 
1997 (Splawski et al., 1997); the gene located on the chromosome 21 (21q22.1-22.2), KCNE1 
(MinK), encodes a single transmembrane protein (KCNE1) that associates with Kv7.1 to form 
the repolarizing current IKs (Barhanin et al., 1996;Sanguinetti et al., 1996). KCNE1 is 
implicated in less than 1% of Long QT Syndrome mutations (Tester et al., 2005), this is 
probably due to the small size of the protein. 
Like the Kv7.1 protein, KCNE1 “loss of function” mutations are involved in the 
autosomal dominant Romano-Ward syndrome as well as in a rare form of the autosomal 
recessive Jervell and Lange-Nielsen syndrome. 
c) Long QT Syndromes involving adaptor protein 
Mutations in nearly all ion channels involved in the AP have been linked to LQTS. 
However 30% of patients with clinical LQTS are still unclassified (Ehrlich, 2007). It 
becomes clear that mutation in proteins involved in the modulation of ion channels can cause 
LQTS as efficiently as mutations in ion channels themselves. The number of Long QT 
Syndrome involving the mutation of adaptor proteins is increasing and to date, three adaptor 
proteins of ion channels have been involved in LQTS. 
Ankyrins are large scaffolding proteins that link the spectrin-based membrane skeleton 
to various membrane proteins (Bennett & Baines, 2001). In the cardiomyocytes, the Na+/K+ 
ATPase pump, the Na+/Ca2+ exchanger and the inositol triphosphate receptor (InsP3R) 
proteins interact with the ankyrin-B (B for broadly expressed). Ankyrin-B mutations lead to 
an increase in intracellular Ca2+ concentration due to an alteration of the Na+/K+ ATPase 
pump and the Na+/Ca2+ exchanger. This imbalance in intracellular Ca2+ concentration leads to 
the failure of the heart (Mohler et al., 2003). 
Caveolins are membrane scaffolding proteins that are implicated in endocytosis, lipid 
homeostasis and signal transduction (Williams & Lisanti, 2004). Caveolin-3 colocalizes with 
Nav1.5 channels in the plasma membrane of cardiomyocytes. Mutations in the CAV3 gene 
result in an increase in Nav1.5 currents, leading to a sustained inward current throughout the 
AP duration and giving rise to QT prolongation (Vatta et al., 2006). 
AKAPs (A-Kinase Anchoring Proteins) are scaffolding proteins that determine the 
subcellular localization of PKA (Protein Kinase A) and other intracellular signalling partners 
in the proximity of the targeted protein in order to increase efficiency of signal transduction 
(Wong & Scott, 2004). Mutation in AKAP9 (Yotiao) impair Kv7.1 regulation by PKA (Chen 
et al., 2007) and induce LQTS. 
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B - Potassium channels 
1) Structure 
The K+ channels are found in nearly all living organisms. So far, over 80 mammalian 
genes (Honore, 2007) have been identified. As mentioned above, K+ channels are central for 
the proper function of the heart, but they are also involved in a lot of other physiological 
processes, such as the neuronal action potential, the modulation of insulin secretion by the 
pancreatic cells, and the smooth muscle relaxation in the bladder. 
Voltage-gated K+ channels are tetramers (Figures 5A and 6A) with each subunit 
composed of 6 transmembrane segments (S1-S6). The transmembrane segments are divided 
into two main domains: a voltage-sensing domain (S1-S4) and a central pore domain (S5-S6). 
Between the S5 and the S6 transmembrane segments, a loop is partially crossing the lipid 
bilayer; this loop is called the P-loop or pore lining loop. It contains a highly conserved 
amino-acid sequence (TVGYG) among K+ channels (Heginbotham et al., 1994). It 
contributes to the selectivity filter of the channel which discriminates K+ over other ions. 
A detailed understanding of how K+ channels function is emerging from the work of 
Roderick MacKinnon and his group (Doyle et al., 1998;Long et al., 2005;Long et al., 2007). 
Their work explained how two important features of ion channels could co-exist; specifically 
the high selectivity (1000 times more selective for K+ than Na+ ions) and the high flux rate 
(≈108 ions / sec). The K+ channel structure is characterized by a big water cavity facing the 
cytoplasm. The selectivity filter is short (12Å) and is located in the outer leaflet of the 
membrane (Figure 5B). As a consequence K+ ions, which are attracted into the water cavity 
by the negative ends of the pore helix dipoles, will cross about two-thirds of the plasma 
membrane before reaching the selectivity filter. During this part of the transmembrane 
journey the K+ ions stay hydrated (i.e. the polar water molecules are organized around K+ 
ions with their oxygen moieties facing the cations), creating a hydration shell. The selectivity 
filter is composed of four consecutive binding sites for K+ ions (Figure 5C). In each of these 
sites a dehydrated ion can interact with 8 partial-charged oxygen atoms (main-chain carbonyl 
or side-chain hydroxyl atoms). Thus the K+ ions are stabilized by the oxygen atoms of the 
filter (effectively replacing the hydration shell). Two K+ ions are present at the same time in 
the pore but separated by a water molecule (in 1,3 or 2,4 configurations) (Morais-Cabral et 
al., 2001). Therefore the K+ ions present in the selectivity filter are displaced toward the 
extracellular solution by electrostatic repulsion from the following K+ ion entering the pore. 
The concentration of K+ ions is greater inside than outside the cell. In addition, the 
cell has a membrane potential, mostly maintained by the Na+/K+ pump, with the cytosol 
being more negative than the outside of the cell. When a K+ selective ion channel opens, the 
K+ ions will diffuse outside the cell, following their electrochemical gradient until the 
equilibrium potential for K+ ions is reached. This equilibrium potential can be calculated by 
the Nernst equation: 
[ ]
[ ]i
o
eq
X
X
zF
RT
E ln=  
where R is the universal gas constant (8.31 J K-1 mol-1), T is the temperature in Kelvin, z is 
the elementary charge, F is the Faraday constant (9.65x104 C mol-1) and X is the 
concentration of K+ inside and outside the cell. 
The calculated equilibrium potential for K+ ions is -98 mV, which is very close to the 
membrane potential of cardiomyocytes (-80 mV), meaning that K+ ions are the major 
contributor of the membrane potential. 
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Figure 5: K+ channels structure. A) Top (left) and side (right) views of Kv1.2 tetramer. Each subunit is shown in 
a different colour. K+ ions are purple. The voltage-sensor domain of each subunit is facing the corner of the adjacent subunit 
(Tombola et al., 2006). B) The KcsA K+ channel with front and back subunits removed. The pore helices are shown in red 
and selectivity filter in yellow; the electron density along the ion pathway is shown in a blue mesh. The outer and inner 
helices correspond to S5 and S6. The K+ ions are in blue and the water molecules in red. The water cavity, containing K+ 
ions in solution, is located below the selectivity filter (MacKinnon, 2004). C) Four K+ binding sites in the KcsA K+ channel 
made by oxygen atoms. One K+ ion interacts with 8 different oxygen atoms (Gouaux & MacKinnon, 2005). 
 
The mechanism that allows the channel to change from the open to the closed 
conformation is referred to as gating. In voltage-gated ion channels, the gating is due to a 
movement of charged moieties in the protein (gating charges) within the lipid bilayer. The 
equivalent of charge moving per channel subunit is 3, meaning that the channel needs the 
movement of 3 equivalent charges across the lipid bilayer to open. It is generally accepted 
that the gating charges are positively charged residues located at every third position in the 
S4 helix. Several studies showed that the first 4 arginines of S4 are the most relevant for 
voltage sensing (Aggarwal & MacKinnon, 1996;Jiang et al., 2003;Seoh et al., 1996). In 
contrast to what was believed (Bezanilla, 2002), the first crystal structure of a voltage-
dependent K+ channels (Jiang et al., 2003) showed that the S4 segment (containing the 
A 
B C 
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arginine residues) is located at the protein-lipid interface. It was later supported by other 
studies, showing that the positive residues of the S4 segment were interacting with the 
phosphate groups of the lipid molecules (Cuello et al., 2004;Schmidt et al., 2006;Xu et al., 
2008b). These interactions provide an appropriate environment for the energetic stability and 
operation of the voltage-sensing machinery (Schmidt et al., 2006). 
Although the nature of the voltage-sensor is well accepted, the movements of the S4 
segment within the lipid bilayer is still a matter of great controversy (Tombola et al., 2006). 
Nevertheless, recent findings tend to show that the perpendicular movement of the S4 
segment within the plasma membrane is around 6-8 Å (Campos et al., 2007;Pathak et al., 
2007) and that S4 rotates approximately 180° during gating. 
 
2) The potassium channels diversity 
The K+ channels family is the largest ion channels family (Robbins, 2001). It is 
composed of five families (corresponding to five types of pore forming α-subunits), based on 
the number of transmembrane domain (TMD) and the number of P loop contained in the 
proteins (Figure 6) (Grissmer, 1997). 
By far, the biggest family of K+ channels is the 6TMDs-1P family (Figure 6A). It is 
also called the voltage-gated K+ (Kv) channels family. It is composed of twelve sub-families 
(Kv1-Kv12), related to a total number of 40 genes (Gutman et al., 2005). The Kv7 subfamily, 
previously called KCNQ family, is composed of five members (Robbins, 2001): Kv7.1, which 
will be discussed in details below; the brain specific Kv7.2, Kv7.3 and Kv7.5, which are 
responsible for regulating the overall cellular excitability of neurons and form the M-current 
(Hernandez et al., 2008b); and Kv7.4, which mediates K
+ efflux in the inner ear (Petersen, 
2002). 
The other 4 families of K+ channels (Figure 6B-E) are composed of: the 2TMDs-1P 
family (inward-rectifier channels) (Bichet et al., 2003), the 4TMDs-2P channels (“leak” 
channels) (Lotshaw, 2007), the 7TMDs-1P family (Big conductance K+ channel, BK channel) 
(Nardi & Olesen, 2008) and finally, the 8TMDs-2P channels (only found in yeast). 
 
Even though the K+ channels family is very large, nature has found an additional way 
to increase the diversity of K+ channels even more, through gene-splicing. The DNA and the 
premature mRNA are composed of introns (intragenic regions, which are non-coding regions) 
and exons (regions which will be expressed) (Gilbert, 1978). During the transcription of the 
DNA into the mature mRNA, introns are removed and only exons are finally assembled 
(spliced together). The sites where the splicing occurs are variable giving rise to many 
versions of the same protein. Alternative splicing is a mechanism by which the number of 
protein isoforms produced by a single gene can be considerable (from few to thousands) 
(Florea L., 2008), augmenting then the diversity of the produced proteins. A number of K+ 
channels protein isoforms have been identified but it is likely that this amount is 
underestimated. 
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Figure 6: The five known families of K+ channels corresponding to five pore-forming α-subunit types. For 
each channel family, individual subunits or monomers (red) associate with other similar monomers (blue) creating 
multimeric channels. For each channel a schematic top-view of assembly is shown above the monomer topology. A) The Kv 
channels are tetramers formed by the association of monomers each having six transmembrane domains and one P-loop 
(6TMD-1P monomers). B) The Kir channels are tetramers formed by association of 2TMD-1P monomers. C) The ‘leak’ K 
channels are dimers formed by association of 4TMD-2P monomers. D) The BK channels are tetramers formed by the 
association of 7TMD-1P monomers. E) The exact stoichiometry of the 8TMD-2P channels is still unknown. (Choe, 
2002;Coetzee WA & Rudy B, 2005). 
 
The diversity of currents produced by K+ channels α-subunits is further increased by 
association with β-subunits. β-subunits are non-pore-forming proteins that affect K+ currents’ 
biophysical properties, pharmacology, trafficking and modulation by intracellular signalling. 
Following the same classification as for the α-subunits, there are four different families of β-
subunits (McCrossan & Abbott, 2004). The only family that I will talk about in details later is 
the 1TMD-0P β-subunits (also called KCNEs); it can associate with some members of the 
voltage-gated Kv7 and Kv11 subfamilies (Pourrier et al., 2003). 
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3) The IKs current 
In the heart, the IKs current is commonly related to channels formed by association of 
the α-subunit Kv7.1 and the β-subunit KCNE1. Although there is no doubt about the identity 
of the IKs α-subunit, the composition of β-subunits present in the complex has been recently 
subject to doubts (Manderfield & George, Jr., 2008;Wu et al., 2006). 
a) α-subunit 
The Kv7.1 channel was the first member of the Kv7 channel family to be discovered 
and was cloned in 1996 (Wang et al., 1996). It is a 676 amino-acids long protein with a 
6TMD-1P topology (Figure 6A and 7A) i.e. it has six transmembrane domains (S1-S6) and a 
pore loop. The S4 segment, containing the positively charged residues responsible for the 
voltage-dependence of the channel, contains only four arginine residues, compared to six for 
the other family members. 
Kv7.1 channels have the highest expression levels in the heart and the kidney (Wang 
et al., 1996), and are expressed to a lesser extent in other epithelia (lung, placenta, inner ear, 
colon, pancreas). In the heart, Kv7.1 is not found alone but associated with the KCNE1 β-
subunit and form the channels underlying the IKs current (Noble & Tsien, 1969;Noble & 
Tsien, 1968). This current is present in all regions of the heart, except in the AV node 
(Brahmajothi et al., 1997;Sato et al., 2000). Two isoforms of Kv7.1 have been identified in 
the heart (isoform 1 and 2). Even though the isoform 1 of the Kv7.1 channel and KCNE1 are 
uniformly expressed across the ventricular wall, Kv7.1 isoform 2 is reported to be highly 
expressed in the ventricular midmyocardium (M cells) and suppresses the overall amount of 
IKs current in these cells by a dominant negative effect (Demolombe et al., 1998;Pereon et al., 
2000). 
When heterologously expressed in Xenopus laevis oocytes or in mammalian cells, 
Kv7.1 channels produce a slowly activating, slowly deactivating (i.e. having a slow transition 
between the open and the close state) and almost non-inactivating (non-conductive state 
under continuous stimulation) K+ current. As discussed above, Kv7.1 “loss of function” 
mutations induce the Long QT Syndrome type 1. On the other hand, “gain of function” 
mutations, which increase the amount of repolarization current IKs, lead to reduction of the 
AP duration and thus induce the Short QT Syndrome (Schimpf et al., 2008). “Gain of 
function” mutations can also induce atrial fibrillation (Chen et al., 2003b). 
Sequence analysis of Kv7.1 channels’ C-terminus predicts four helical regions (named 
helices A-D) (Yus-Najera et al., 2002). In the C-terminus, Schmitt and co-workers (Schmitt 
et al., 2000) found a 100 amino-acids domain important for the assembly of the four α-
subunits. This domain, called the assembly domain or A-domain, has a similar sequence in all 
Kv7 channels (Howard et al., 2007). It is composed of three regions: a Head (helix C), a 
Linker and a Tail (helix D) (Figure 7A). The helical Tail region, which contains periodic 
heptad repeats with hydrophobic residues at every first and fourth position, forms an 
interaction motif. This interaction motif is responsible for the tetramerization of the channel 
and the subunit specificity. The four subunits tetramerize in a coiled-coil complex (Figure 
7C) (Jenke et al., 2003;Schwake et al., 2006). Kv7.1 subunit do not make tetramers with other 
members of the Kv7 channels family (Schwake et al., 2003). This feature can be explained by 
the differences in Kv7.1 compared to other members of the Kv7 family in one of the two Tail 
region networks that make interhelical contacts between the α-subunits (Figure 7C). The 
amino-acids involved in the Kv7.1 network 2 (K598, Q601, D603, R605 and A607) cannot 
make electrostatic interactions with the amino-acids present in the other members of the 
family (Q625, S628, E630, K632 and D634 in Kv7.4) (Howard et al., 2007). Furthermore, the 
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helix D in Kv7.1 is two helical turns longer than in the other Kv7 channels which increase 
Kv7.1 affinity for other Kv7.1 subunits. In addition, Kv7.1 contains a metal coordination site 
capping its assembly which may provide an additional mechanism for assembly partner 
specificity (Wiener et al., 2008). 
 
 
Figure 7: Tetrameric association of Kv7.1 channels and with KCNE1. A) Topology cartoon of one Kv7.1 α-
subunit and one KCNE1 β-subunit. The transmembrane segments are in pink, with the S4 segment in red, containing the 
number of positively charged arginine residues (+). P is the pore-lining loop. The lengths of the helices are representative of 
the relative size of the N- and C-termini in both Kv7.1 and KCNE1. Kv7.1 contains four helices in its C-terminus (helix A-D) 
and KCNE1 contains three smaller helices (Kang et al., 2008;Kanki et al., 2004;Yus-Najera et al., 2002). B) Top view of the 
arrangement of transmembrane segments in a tetrameric Kv7.1 channel based on the crystal structure of Kv1.2 (2A79.pdb). 
The four Kv7.1 subunits are colour coded light blue, pink, white and light gray. S4-S5 linkers are marked as rectangles 
connecting S4 and S5. The KCNE1 transmembrane domain is in a putative “KCNE-binding pocket”, where KCNE1 makes 
contacts with S4, S6 and S1 of three separate Kv7.1 subunits (Xu et al., 2008a). C) Intra- and intermolecular electrostatic 
interactions of the Kv7.4 A-domain Tail coiled-coil (helix D). Ribbon diagram shows helices coloured green, orange, purple 
and gray. The N- and C-terminal ends of the green subunit are indicated. Network 1 and network 2 interactions between the 
side chains (shown as sticks) of the green and orange subunits. Salt bridges (black lines) and hydrogen bonds (dotted lines) 
are indicated. Side chains labels are colour coded to indicate the subunit of origin. Kv7.4 and corresponding Kv7.1 amino-
acids involved in both networks are indicated (Howard et al., 2007). 
b) β-subunits 
Although Kv7.1 does not assemble with any of the other Kv7 channels, it can assemble 
with all KCNE β-subunits (KCNE1-5). The KCNE proteins are 1TMD-0P proteins with each 
an extracellular N-terminus and an intracellular C-terminus (Figure 7A). All members of the 
family are expressed in the ventricles of the heart (Lundquist et al., 2006), meaning that they 
are all potential subunits of the IKs current. Nevertheless, according to the recent literature, 
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only KCNE1, KCNE2, KCNE3 and KCNE4 are likely to be of physiological relevance in the 
heart (Bendahhou et al., 2005). 
KCNE1 (KCNE1 gene on chromosome 21q22.1-q22.2) is a 129 amino-acid long 
protein. When KCNE1 was cloned, it was thought to encode the protein underlying the 
cardiac IKs current, since exogenous expression in Xenopus laevis oocytes gave rise to IKs-like 
currents (Takumi et al., 1988). However, exogenous expression in mammalian cell lines did 
not generate the same currents, which led Blumenthal and colleagues to suggest that KCNE1 
is binding to an endogenous oocyte-specific factor and that the resulting complex produces 
IKs-like currents (Blumenthal & Kaczmarek, 1994). Their suggestion was confirmed in 1996 
when two different groups cloned Kv7.1 and show that Kv7.1 interacts with KCNE1 to form 
the IKs current (Barhanin et al., 1996;Sanguinetti et al., 1996). This current is mostly present 
in the heart but also in the inner ear and the kidney (Lang et al., 2007). 
Compared to Kv7.1 channels alone, Kv7.1-KCNE1 channel complexes produce 
currents with a slower activation rate; a four-fold increase in the unitary conductance (Sesti & 
Goldstein, 1998) leading to an increase in the whole-cell current density (Barhanin et al., 
1996;Sanguinetti et al., 1996); a loss of inactivation (Tapper & George, Jr., 2000); and an 
alteration of the intracellular regulation and pharmacology of the complex (Panaghie & 
Abbott, 2006). 
Although there is still no universal agreement on the stoichiometry of the IKs complex, 
there is growing evidence that there are two KCNE1 for four Kv7.1 subunits (Chen et al., 
2003a;Morin & Kobertz, 2008). Several groups tried to identify the regions involved in 
KCNE1-Kv7.1 interaction. There is a general concordance in that KCNE1 is in contact with 
transmembrane domains of two or three different Kv7.1 subunits (Figure 7B) (Kang et al., 
2008;Shamgar et al., 2008;Xu et al., 2008a). The discrepancies might be related to different 
states of the channels (i.e. open or closed) (Kang et al., 2008). Nevertheless, there is 
agreement in that the mid-S6 region of Kv7.1 is important for KCNE1 interaction (Melman et 
al., 2004) and is in contact with the mid-transmembrane α-helix of the β-subunit (Panaghie et 
al., 2006). There is also evidence that the outer S1 segment of Kv7.1 is in contact with the 
outer transmembrane domain of KCNE1 (Xu et al., 2008a). Even though the three-
dimensional structure of KCNE1 has been recently obtained, we still lack direct evidence of 
the structure of Kv7.1/KCNE1 complex (Kang et al., 2008). 
The β-subunit KCNE2 converts Kv7.1 currents in constitutively active channels that 
are pH-sensitive (Grahammer et al., 2001;Tinel et al., 2000). Kv7.1/KCNE2 complex forms 
channels that are critical for gastric acid secretion in parietal cells (Heitzmann & Warth, 
2008). Furthermore KCNE2 can make a “triple subunit complex” with Kv7.1 and KCNE1 
(Toyoda et al., 2006;Wu et al., 2006) and then be part of the IKs current. Although the 
electrophysiological data are contradictory on the effect of KCNE2 on IKs (increase or 
decrease in current), it seems that the IKs current can be formed by a third subunits, namely 
KCNE2. 
KCNE3 has the same effect as KCNE2 on Kv7.1 currents but is mainly expressed in 
intestine crypt cells (Schroeder et al., 2000). Nonetheless it is the third most abundant KCNE 
in the heart after KCNE1 and KCNE4 (Bendahhou et al., 2005). 
There are discrepancies regarding the effect of KCNE4 on Kv7.1 currents, some 
observe an activation (Teng et al., 2003) and others an inhibition of the current (Grunnet et 
al., 2002;Teng et al., 2003). Although no electrophysiological data are available, it was 
shown with immunoprecipitation experiments that KCNE4 can co-associate with 
Kv7.1/KCNE1 complex (Manderfield & George, Jr., 2008) and might then be part of the IKs 
current. 
The localization of the KCNEs in the different chambers of the heart is an important 
factor in identifying the partners present in the IKs complex but this information is still 
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unknown. Lundby and collaborators demonstrated that depending on the KCNE present in 
the IKs complex containing a mutated Kv7.1 channel (Q147R), the outcome currents were 
very different and could explain that a patient was diagnosed with both atrial fibrillation and 
Long QT Syndrome (Lundby et al., 2007). 
C - Kv7.1 intracellular regulation 
In this paragraph, I will discuss in details what is known about Kv7.1 intracellular 
regulation through N- and C-termini binding. I will then introduce and summarize the work I 
have done during the last three years (the complete studies being appended in the following 
chapters). 
More than 20% of the human genome encodes proteins involved in transmembrane 
and intracellular signaling pathways (Tasken & Aandahl, 2004). With the increasing number 
of mutations in adaptor proteins involved in Long QT Syndrome, it becomes clear that 
perturbation of the ion channels’ intracellular regulation can be as life threatening as 
mutations in the cardiac ion channels themselves. A better understanding of the cardiac ion 
channels’ intracellular regulation will lead us to a better understanding of the function of the 
heart and then of the Long QT Syndrome. 
Kv7.1 N-terminus has mostly been implicated in trafficking and has only been show to 
interact with the cytoskeleton microtubules (see below). On the other hand, Kv7.1 channels 
C-terminus has been shown to interact with a number of proteins. It is probably partly due to 
its size; in Kv7.1 the C-terminus accounts for half of the molecular weight of the entire 
protein (328 amino-acids out of 676). Several interaction motifs have been identified and are 
involved in the binding of intracellular regulatory proteins. 
1) Cytoskeleton 
β-tubulin has been shown to interact with Kv7.1 N-terminus (Nicolas et al., 2008). β-
tubulin is the protein subunit of microtubules, one of the three major classes of filaments of 
the cytoskeleton. Nicolas and colleagues demonstrated that PKA-dependent activation of the 
IKs current during β-adrenergic stimulation was modulated by the microtubules 
polymerization (Nicolas et al., 2008). Furthermore Grunnet and co-workers showed that the 
first 95 amino-acids of Kv7.1 are necessary for its cell-volume regulation sensitivity via 
interaction with the cytoskeleton (Grunnet et al., 2003). However the β-tubulin interaction 
with Kv7.1 is not involved in current modulation by cell volume changes (Nicolas et al., 
2008). 
2) Calmodulin 
Calmodulin is a small soluble Ca2+-binding protein of 148 amino-acids present in all 
eukaryote cells (Jurado et al., 1999) that helps to relay the cytosolic Ca2+ signal. It is a 
monomer composed of two lobes (N and C) with each a pair of Ca2+-binding EF-hands 
motifs (Haeseleer et al., 2002). 
In ventricular myocytes (Tohse et al., 1987) and Purkinje cells (Scamps & Carmeliet, 
1989), an increase in intracellular Ca2+ concentration stimulates the delay rectifier K+ current 
(IK). Later it was shown that it is the slow component of the IK current (IKs) that is Ca
2+ 
sensitive (Tohse, 1990). Yus-Najera and colleagues demonstrated that calmodulin binds to 
the C-terminus of Kv7 channels through the helices A and B (Yus-Najera et al., 2002) (Figure 
8). The helix A contains a sequence recognition for calmodulin, called the IQ motif (Isoleucin 
Glutamine motif), whereas helix B contains a modified variant of the IQ motif, called 1-5-10 
motif, based on the conserved hydrophobic residues (Rhoads & Friedberg, 1997;Yus-Najera 
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et al., 2002). Long QT Syndrome mutations near the IQ motif impair calmodulin binding, 
confer inactivation and reduce current amplitude (Shamgar et al., 2006). 
Despite some controversies (Bai et al., 2005;Gamper et al., 2005;Shamgar et al., 
2006), it seems that Kv7.1 channels and the IKs current (Kv7.1 associated with KCNE1) are 
stimulated by an increase in intracellular Ca2+ concentration via calmodulin (Bai et al., 
2005;Shamgar et al., 2006). Moreover in Kv7.1 channels, calmodulin is not only responsible 
for the Ca2+ sensitivity of the channel but also for the proper folding of the C-terminus and 
the correct delivery of the channel to the cell surface (Shamgar et al., 2006). 
 
 
Figure 8: Structure of Kv7.1 channels and interaction sites on the C-terminus. The C-termini of only two 
subunits are depicted for clarity. The Kv7.1 C-terminus exhibits interaction sites with calmodulin at helices A and B, with 
PIP2, with Yotiao at helix D and finally with Nedd4-2. In addition to potential role in channel trafficking, the coiled-coils C 
and D may correspond to subunit dimerization and tetramerization modules, respectively. Neighbouring subunits would 
form a dimer at helix C. The helix C complex may undergo dimerization of its dimeric coiled-coil while the helix D complex 
is depicted as a stable, tetrameric parallel coiled-coil, as seen in the crystal structure (Howard et al., 2007). (Haitin & Attali, 
2008). 
3) PIP2 
Phosphatidylinositol 4,5-bisphosphate, or PIP2, is an acidic phospholipid with a myo-
inositol in the head group. It is a minor component (1%) of the acidic lipids present in the 
plasma membrane and is located in the inner leaflet of the bilayer. For decades PIP2 was 
known to be involved in the Ca2+ signalling and to be the precursor of the second messengers 
DAG (DiAcylGlycerol) and IP3 (Inositol-1,4,5-trisphosphate). PIP2´s effect on ion transport 
proteins is only known since 1984 (Choquette et al., 1984). The first ion channel to be found 
PIP2 sensitive was the ryanodine-sensitive Ca
2+release channel (Chu & Stefani, 
1991;Kobayashi et al., 1989). 
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Byung-Chang Suh and Bertil Hille in 2002 reported the first Kv7 channel to be PIP2 
sensitive (Suh & Hille, 2002). They showed that activation of the muscarinic acetylcholine 
receptor (mAChR) induces the breakdown of PIP2, leading to inhibition of the M-current, 
formed by Kv7.2/Kv7.3 heteromers (Zhang et al., 2003). Since then, all Kv7 channels and 
Kv7.1 in particular have been shown to be activated by an increase in PIP2 concentration 
(Zhang et al., 2003). Furthermore PIP2 activates the IKs current by stabilizing the open 
channel configuration (Loussouarn et al., 2003). 
Despite extensive work, the precise PIP2 binding site is still not known. It is believed 
to be composed of basic residues, interacting with the negatively charged phospho head 
groups of PIP2, but no consensus site has been found (Suh & Hille, 2008). It can also be that 
PIP2 does not need a specific binding site but just a cluster of basic residues (Gamper & 
Shapiro, 2007). Furthermore the disposition of the positively charged amino-acids in Kv7.1 
C-terminus is very different compared to other Kv7 channels, which makes it even more 
difficult to find a consensus site for PIP2 binding (Hernandez et al., 2008a). Nevertheless 
Byung-Chang Suh and Bertil Hille (Suh & Hille, 2008) suggest that the PIP2 binding site is a 
~50 amino-acids stretch in the C-terminus (Figure 8). 
4) Yotiao 
Yotiao belongs to the AKAP family. The AKAPs (A-Kinase Anchoring Proteins) are 
a family of proteins characterized by their ability to co-purify with the cAMP-dependent 
protein kinase (PKA) catalytic subunit. They also have a unique localization signal and are 
able to form complexes with other signalling molecules. To date, more than 50 members have 
been identified (Tasken & Aandahl, 2004) and 13 different are expressed in cardiac tissue 
(Ruehr et al., 2004). PKA, a Serine/Threonine protein kinase, is activated in response to an 
increase in cytosolic cAMP (cyclic Adenosine MonoPhosphate). The cAMP signaling 
pathway is one of the most common but at the same time one of the most versatile pathway in 
mammals (Sutherland, 1972). AKAPs’ function is to target the cAMP signal to specific 
compartments of the cell and to gather all necessary partners together(enzymes, as well as the 
downstream target) (Zaccolo & Pozzan, 2002). 
Yotiao was initially found in the brain (Lin et al., 1998) and associated to the NMDA 
(N-methyl-D-Aspartate) receptor (Westphal et al., 1999). Marks and co-workers showed that 
Yotiao is interacting with Kv7.1 C-terminus by a Leucine zipper motif (helix D, amino-acids 
588-616) (Marx et al., 2002). Yotiao would interact with the outer surface of the coiled-coil 
formed by the four Kv7.1 helices D (Figure 8) (Howard et al., 2007). In addition to PKA, 
Yotiao recruits a phosphatase called PP1 (Protein Phosphatase 1) and forms a 
macromolecular complex that ensures high efficiency and specificity of Kv7.1 modulation 
(Kurokawa et al., 2004). Activation of β-adrenergic receptors during sympathetic nervous 
system stimulation produces an increase in cAMP which induces an activation of PKA that 
phosphorylate Kv7.1 on a single residue, S27 (Figure 9) (Marx et al., 2002). Phosphorylation 
of Kv7.1 induces an increase in IKs current (Kurokawa et al., 2003), which leads to a 
shortening of the AP and thus an increase in the heart rate. It now seems that Yotiao is not 
only an adaptor protein that coordinates enzymatic reactions but is also an active partner in 
the β-adrenergic regulation of Kv7.1 by translating the Kv7.1 phosphorylation-induced 
changes into altered channel activity (Chen & Kass, 2006). Yotiao itself is phosphorylated by 
PKA on S43 and this phosphorylation is necessary for the proper transduction of the signal 
during β-adrenergic stimulation (Chen et al., 2005). 
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Figure 9: Schematic diagram of the IKs/Yotiao macromolecular complex and of the cAMP signaling pathway. 
The transmembrane segments of KCNE1, Kv7.1 and the G-protein coupled receptor are in pink. When an agonist binds to 
and activates a seven-transmembrane G-protein-coupled receptor, the signal is transmitted to the Gαs subunit of the 
heterotrimeric G protein, which then activates adenylyl cyclase. The adenylyl cyclase synthesizes cAMP from ATP, which 
binds to the regulatory subunits of PKA. Yotiao, interacting with Kv7.1 C-terminus, recruits key enzymes, such as PKA and 
PP1, and presents them to the IKs complex. The activated PKA phosphorylates Kv7.1 and Yotiao on S27 and S43, 
respectively (Chen & Kass, 2006;Wong & Scott, 2004). 
5) Trafficking of Kv7.1/IKs 
Several domains of both the N- and C-termini of Kv7.1 have been implicated in the 
trafficking of the channel (Kv7.1 and/or IKs). Removing the region preceding the first 
transmembrane domain (amino-acids 106 to 119) results in Kv7.1 retention in the 
endoplasmic reticulum (ER) (Dahimene et al., 2006). Besides, two motifs (LXL at position 
38-40 and YXXΦ-motif at position 51-54) were found to be important for apical vs. 
basolateral membranes localization in polarized (epithelial) cells (Jespersen et al., 2004). In 
addition to those regions located in the N-terminus, several domains in the C-terminus of 
Kv7.1, as discussed above, are necessary for the proper trafficking of the channel: the 
calmodulin binding domain in the helix A (Shamgar et al., 2006) and the assembly domain in 
the helix D (Kanki et al., 2004). Both helices must be folded properly for the channel to be 
able to exit the ER. Furthermore the very last part of the Kv7.1 C-terminus (amino-acids 659-
665) contains a PY motif (Staub & Rotin, 2006). This motif is recognized by a ligase called 
Nedd4-2, which links ubiquitin, a 76-amino-acids protein, to the channel. This ubiquitylation 
induces internalization and degradation of Kv7.1/IKs channels (Jespersen et al., 2007). 
Furthermore Nedd4-2 is inhibited by SGK1 (Serum- and Glucocorticoid-inducible Kinase 1) 
which enhances the abundance of Na+ channels in the plasma membrane (Debonneville et al., 
2001). SGK1 has also been shown to stimulate the IKs current in response to the release of 
stress hormones such as cortisol (Embark et al., 2003). Seebohm and colleagues recently 
showed that IKs is present in intracellular vesicles that can exocytose and endocytose very 
NH2 
 
COOH 
 
KCNE1 
NH2 
 
HOOC 
Kv7.1 
Helix D 
P 
Yotiao 
NH2 
 
COOH 
S43 P 
PKA 
PP1 
G-protein coupled 
receptor 
Agonist 
Gαs 
Gβγ 
Adenylate 
Cyclase 
ATP 
cAMP 
S27 
Introduction 
__________________________________________________________________________________________ 
______________________________________________________________________________________ 
Nathalie Hélix Nielsen PhD thesis  
18 
rapidly in response to hormonal stimulation (such as cortisol) and that GTPase of the RAB 
family are involved in that process (Seebohm et al., 2007). 
Only one LQTS5 mutant KCNE1 has been involved in mis-trafficking of the IKs 
complex (Bianchi et al., 1999;Krumerman et al., 2004). L51H, located in the N-terminus part 
of the β-subunit, induces the retention of Kv7.1 in the ER. KCNE1-L51H is not a dominant 
negative mutant and probably causes the mis-folding of KCNE1 which then fails to transit 
from the ER to the Golgi (Krumerman et al., 2004). 
There are two kinds of trafficking-deficient proteins: the one having an impaired 
trafficking signal and the one resulting in mis-folding of the protein which then result in the 
retention of the protein in intracellular compartments. 
 
In the first manuscript attached in this thesis, we have identified a novel Kv7.1 
mutation that alters protein trafficking (Schmitt et al., 2007). Kv7.1-M520R mutant was 
found in a German family of seven living members which had a prolongation of the heart-
rate-corrected QT interval (QTc). We decided to clone the mutated gene in the appropriate 
vectors for expression in mammalian cells and Xenopus laevis oocytes. With the patch-clamp 
technique, we first looked at the expression of Kv7.1-M520R alone and did not see any 
Kv7.1-like current. Co-expression with Kv7.1-WT in a 1:1 ratio gave rise to a 50% reduction 
in current compared to WT channels. To investigate whether co-expression with KCNE1 had 
any impact on the phenotype of the mutant channel, CHO-K1 cells were transfected with 
Kv7.1-M520R or Kv7.1-WT channels together with KCNE1 DNA. As expected, Kv7.1-WT 
and KCNE1 gave rise to the typical IKs current (slow activation, slow deactivation and 
increase in whole-cell current amplitude). On the other hand, we could not record any IKs-like 
currents with Kv7.1-M520R and KCNE1 co-expression. However, co-expression of Kv7.1-
M520R, Kv7.1-WT and KCNE1 gave rise to about half the current seen in cells expressing 
Kv7.1-WT and KCNE1. Electrophysiological experiments were performed in CHO-K1 cells, 
in Xenopus laevis oocytes, as well as COS-1 cells in order to avoid any expression system-
dependent results. 
In order to understand the nature of the reduction in currents due to the M520R 
mutation, we performed cellular localization experiments. Kv7.1-WT proteins were targeted 
to the plasma membrane of COS-1 cells whereas Kv7.1-M520R proteins were co-localized 
with the ER protein PDI (protein-disulfide-isomerase) and not found in the plasma 
membrane. Those results demonstrate that Kv7.1-M520R channel is retained in the ER and 
explained the low current-levels seen in the electrophysiological experiments. 
The M520R mutation lies in the helix B of Kv7.1 C-terminus. This region contains 
two overlapping 1-5-10 motifs which are consensus binding motifs for calmodulin. 
Furthermore calmodulin binding is important for the correct delivery of the channel to the 
cell surface (Shamgar et al., 2006). To test whether the mutant channel fails to interact with 
calmodulin, we performed yeast two-hybrid experiments. We showed that Kv7.1-M520R C-
terminus could interact with calmodulin and that the impaired interaction between the two 
proteins was not the cause of the retention of the mutated channel in the ER. 
We have shown that the observed phenotype (QTc prolongation) is the result of a 
decrease in IKs current subsequent to the retention of the channel in the ER. However the 
interaction between the channel and calmodulin does not seem to be impaired. One possible 
explanation is that a weakened interaction between Kv7.1-M520R and calmodulin (not seen 
with the yeast two-hybrid technique) is responsible for the retention of the protein in the ER 
and for the phenotype of the patients. 
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6) Intracellular regulation of Kv7.1 by FHL2 and MAPK3 
In the second manuscript (Nielsen NH et al., in preparation), we decided to look for 
other proteins that could tune channel activity by forming a complex with Kv7.1. We 
performed a yeast two-hybrid assay of a human heart cDNA library and isolated FHL2 as an 
interaction partner for Kv7.1. It has been reported before that KCNE1 was binding to FHL2 
and was necessary to generate IKs currents (Krishnamurthy et al., 2004;Kupershmidt et al., 
2002). Under the conditions used in our experiments however, only Kv7.1 interacted with 
FHL2. FHL2 (Four and a Half LIM-only protein 2) is a heart specific protein that belongs to 
the family of the LIM proteins. The LIM proteins contain a sequence of 55 amino-acids with 
eight highly conserved residues (mostly cysteine and histidine) that bind zinc. This LIM 
sequence is a modular protein-binding interface that mediates protein-protein interactions 
(Kadrmas & Beckerle, 2004). FHL2 belongs to a family of four cytoskeleton-associated 
proteins (ACT and FHL1-3) that travel between the cytoplasm and the nucleus in order to 
influence gene expression (Johannessen et al., 2006). We demonstrated that all four and a 
half LIM domains of FHL2 are necessary for binding to Kv7.1 channel. Furthermore, 
removing the N-terminus of the channel impaired the binding, meaning that the FHL2 
binding domain is located in the first 121 amino-acids of Kv7.1. 
We assessed FHL2 mRNA expression in the major compartments of the heart by 
performing RT-PCR experiments. For that purpose, we used total RNA isolated from left and 
right atria, and left and right ventricles as well as from total brain with primers specific for 
Kv7.1, FHL2 and the housekeeping gene GAPDH (Glyceraldehyde-3-phosphate 
dehydrogenase) (Barber et al., 2005). FHL2 was expressed in all compartments of the heart 
with a lower expression level in left atria compared to GAPDH expression. 
Immunolocalization of FHL2 and Kv7.1 on both rat and guinea-pig cardiomyocytes showed 
that both proteins are localized in the T-tubules, as shown previously (Li et al., 
2001;Rasmussen et al., 2004). In addition, we found the proteins to overlap in some parts of 
the T-tubular system. 
We next investigated the functional impact of FHL2 on Kv7.1 and IKs currents 
(Kv7.1/KCNE1). We could not see any differences between the currents recorded from 
oocytes injected with Kv7.1 or Kv7.1/KCNE1 with or without FHL2 (results in CHO-K1 cells 
were identical, data not shown). However, the currents resulting from the expression of Kv7.1 
and KCNE1-D76N, a LQTS5 mutation that fails to induce detectable currents (Splawski et 
al., 1997), were rescued by co-injection with FHL2. The rescuing effect was also observed 
with another LQT5 mutant, namely S74L, but to a less pronounced extend. Moreover, 
injection of FHL2 protein into oocytes expressing Kv7.1/ KCNE1-D76N induced an increase 
in current. This was not seen in oocytes injected with Kv7.1/ KCNE1-WT. Finally we could 
demonstrate that the N-terminus of Kv7.1 was essential for FHL2 rescue. 
In an approach to link the clear functional effect of FHL2 on mutant IKs complexes 
and its interaction with Kv7.1 as evidenced by the yeast two-hybrid assays, we set out to find 
a possible linker between the two proteins. In the Kv7.1 N-terminus we identified a consensus 
site for MAPK3 phophorylation (PXS/TP, amino-acids 64-67). MAPK3 (Mitogen-Activated 
Protein Kinase 3), also called ERK1/2 (Extracellular signal-Regulated Kinase 1/2), is a 
serine/threonine protein kinase and is part of one of the three major MAP Kinase signaling 
cascades (ERK, p38 and JNK) (Qi & Elion, 2005). ERK1 and ERK2 have been involved in 
proliferation, tumorigenesis, differentiation, development and cell survival. We could not see 
any direct effect of MAPK3 inhibitor PD98059 on CHO-K1 cells transfected with Kv7.1 
(data not shown), neither could we see an effect when Kv7.1 was co-transfected with an 
active form of MAPK3 (data not shown). However the Kv7.1-S66D mutant channel, 
mimicking phosphorylation of Kv7.1 by MAPK3, when co-injected with KCNE1-D76N 
prevented FHL2 rescue of the IKs mutated current. 
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In our ongoing studies, we are assessing the interplay of these interaction partners by 
performing (dual bait) two-hybrid experiments with wild-type and mutated Kv7.1 channels in 
both MAPK3 consensus phosphorylation and docking sites (Sharrocks et al 2000). 
Furthermore, we are assessing the functional consequences of these mutations in 
heterologous expression experiments. 
 
D - Conclusion 
It’s tempting to think by looking at the figure 4, that with the cloning of the ion 
channels implicated in the currents shaping the cardiac action potential, the secret of the 
function of the heart is almost cracked. However, the currents recorded in cells exogenously 
expressing the cloned ion channels do not exactly resemble the ones recorded in the native 
cells. Therefore a consensus saying that “ion channels are not islands but rather a complex 
and dynamic assembly of many different proteins”, as summarized by McCrossan and 
Abbott, is emerging (McCrossan & Abbott, 2004). The discovery and cloning of β-subunits 
allowed researchers to reproduce, in some cases, native currents. However some fine tuning 
of the ion channels is still missing. What we see today is that an increasing number of 
proteins associate with ion channels and modulate their activity. This is not only true in the 
cardiac field but seem to be a general mechanism for the cell to obtain a fast and localized 
response following an extracellular stimulus. The ion channels are macromolecular 
complexes formed by many different proteins like kinases, phosphatases, cytoskeletal 
elements, scaffolding proteins and generic mediators of protein-protein interaction and last, 
not least β-subunits. 
Identification of intracellular partners of ion channels, and of Kv7.1 in particular, will 
help us, researchers, to have a better understanding of the cardiac AP and also of the general 
function of the heart. Mutations causing diseases in cardiac specific proteins (ion channels 
and others) help us identifying the different partners involved in the regulation of the activity 
of the heart.  
Yet, there are still questions we cannot answer and that the field is just beginning to 
address:  
- What determines the penetrance of a mutation (different phenotype for the same 
genotype)? What determines the severity of the cardiac arrhythmias in patients 
carrying the same mutation? Are polymorphisms (common genetic differences among 
a subset of the population) involved? 
- What is the molecular basis for gender differences observed in e.g. the Long QT 
Syndrome? Can we link this phenomenum conclusively to hormonal regulation or do 
we have to consider epigenetic regulation? 
- How stable are the ion channel complexes, how dynamic are the processes, are they 
developmentally regulated? 
Identification of all the interactions partners and regulatory mechanisms will provide 
new targets for more effective treatments against cardiac arrhythmias. 
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II PAPER 1: THE NOVEL C-TERMINAL KCNQ1 MUTATION 
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Appendix A. Supplementary data 
 
 
Fig. S1. Electrophysiological characterization of Kv7.1-WT and Kv7.1-M520R. CHO-K1 cells were transiently 
transfected and whole-cell currents were measured using single-electrode voltage-clamp. Currents were elicited using the 
voltage-clamp protocol shown in the insert in C. A: Kv7.1-WT. B: Kv7.1-WT+Kv7.1-M520R in a 1:1 ratio. C: Kv7.1-
M520R. D: The current–voltage relationships measured at steady-state as indicated by the black arrow on the voltage-clamp 
protocol. Open circles: Kv7.1-WT, n = 16. Open squares: Kv7.1-WT +Kv7.1-M520R, n = 12. Open triangles: Kv7.1-M520R 
alone, n = 14 and filled squared: Native CHO-K1 cells, n = 16. Mean values ±SEM are shown. 
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III PAPER 2: FHL2 AND MAPK3 ARE INVOLVED IN THE 
REGULATION OF THE IKS CURRENT IN THE HEART 
A – Introduction 
In the heart, opening of potassium (K+) channels, and the resulting outflow of K+ ions, 
is the most important parameter in determining the length of the action potential. In many 
species, including humans, the cardiac repolarisation current (IK) is the sum of two distinct 
K+ currents, the slowly (IKs) and the rapidly (IKr) activating delayed rectifier currents (Noble 
& Tsien, 1969). IKs is formed by the association of the pore-forming Kv7.1 α-subunit and 
KCNE1 β-subunit (non-pore forming proteins) (Barhanin et al., 1996; Sanguinetti et al., 
1996). The Kv7.1 protein displays the typical topology of Kv channels with four α-subunits 
composing the ion-selective pore, each with cytoplasmic N- and C-termini flanking a 
membrane-inserted core region.  
Mutations in the genes encoding the IKs channels produce the long QT (LQT) 
syndrome, a genetically heterogeneous cardiovascular disease characterized by abnormal 
ventricular repolarisation (Saenen & Vrints, 2008). It is recognized that the potassium 
channel α-subunit Kv7.1 does not act as an independent unit but is part of a macromolecular 
complexe through interaction with the transmembrane β-subunit KCNE1 as well as 
intracellular proteins. In particular, the C-terminal region of Kv7.1 hosts an increasing 
number of interaction interfaces with regulatory proteins (Haitin & Attali, 2008). Protein-
protein interactions create a network that is a key to normal trafficking, targeting, subcellular 
localization and function of voltage-gated ion channels (for review see Marx, 2003). Through 
formation of these complexes, ion channels α-subunits are targets of multiple regulatory 
processes accounting for the fine-tuning of the channel activity. Identification of the different 
molecular components and recognizing the mechanisms underlying the fine tuning of cardiac 
excitability may help understanding pathophysiological conditions in cardiac arrhythmias. 
In contrast to the C-terminus of Kv7.1, knowledge about the role of the N-terminal 
part of the channel protein and its functional link to regulatory pathways is very limited. Our 
laboratory and others have shown that several N-terminal residues are important for channel 
trafficking and targeting (Dahimene et al., 2006; Jespersen et al., 2004). Furthermore, our 
laboratory reported that Kv7.1 channels sense cell volume changes through interaction 
between the cytoskeleton and the N-terminus of the channel protein (Grunnet et al., 2003). 
Recently, Nicolas and co-workers detected a direct interaction between β-tubulin and the 
Kv7.1 N-terminus (Nicolas et al., 2008). This interaction of the channel protein with 
microtubules appeared to be crucial for the β-adrenergic stimulation of the IKs current. 
Signals transmitted by the sympathetic nervous system in response to exercise or emotional 
stress through β-adrenergic stimulation are translated into a rapid increase in heart rate tied 
with a reduction of the ventricular action-potential duration at the cellular level. This is, at 
least in part, accomplished by an increase in the IKs current (Wit et al., 1975). IKs activation 
depends on the phosphorylation of an N-terminal serine residue (S27) in Kv7.1 by adenosine 
3',5'-monophosphate (cAMP)-dependent protein kinase (PKA) (Marx, 2003; Marx et al., 
2002). The kinase is linked to Kv7.1 via the targeting protein yotiao that also brings protein 
phosphatase 1 (PP1) to the complex (Kurokawa et al., 2004). Kv7.1 phosphorylation at S27 is 
independent on the presence of the β-subunit KCNE1. However, the functional effect of PKA 
modulation on the channel activity requires the presence of the β-subunit (Kurokawa et al., 
2003). In addition, Kurokawa and colleagues showed that some KCNE1 mutations, 
associated with LQT syndrome, could disrupt this functional regulation without interfering 
with cAMP-mediated phosphorylation of the channel α-subunit (Kurokawa et al., 2003). 
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These findings point to a complexity of ion channel regulation that may be solved by 
identifying new players (and interconnectors) in cardiac repolarization. 
 
In this study, we performed a yeast two-hybrid screen to discover other signaling 
partners of the IKs complex. We identified the four-and-a-half LIM domain protein 2 (FHL2) 
as an interacting partner of the Kv7.1 N-terminal region. We assessed the functional relevance 
of this interaction in heterologous expression systems. We demonstrated that FHL2 does not 
affect Kv7.1 or IKs currents but is able to rescue some disease-associated IKs channel 
complexes with mutation in KCNE1 (D76N and S74L). This effect was dependent on 
residues in the N-terminal part of the α-subunit. We also demonstrated that ERK1/2 
(MAPK3) phosphorylation is an important partner in the FHL2 rescue of LQT5 mutant 
channels. 
 
B – Material and methods 
1) Molecular biology 
a) Cloning 
For the yeast two-hybrid assay, cDNA encoding the Kv7.1 N-terminus (amino-acids 
(aa) 1-121) was amplified by standard PCR and cloned in frame with the Gal4 DNA binding 
domain into pAS2-1 (Takara Bio Europe/Clontech, France). The open reading frame of FHL2 
(aa 1-279) was amplified by PCR and cloned into vectors suitable for yeast two-hybrid 
analysis or heterologous expression studies. Deletion constructs LIM-H123 (aa 2-220), 
LIMH12 (2-160), LIM-H1 (2-100), LIM-H (2-39), and LIM34 (154-279) of FHL2 containing 
the indicated LIM domains were generated by standard PCR and cloned in frame with the 
Gal4 activation domain into pGAD424 (Clontech). For heterologous expression experiments 
Kv7.1 and KCNE1 wild-type and mutants were cloned into pGEM-HE (Liman et al., 1992) 
for expression in Xenopus laevis oocytes and into pcDNA3.1 (Invitrogen, CA, USA) for 
expression in mammalian cells, respectively. Mutations were introduced by mutated 
oligonucleotide extension using PfuUltraII polymerase (Stratagene Europe, Netherlands) 
from wild-type plasmid templates, digested with DpnI (fermentas, Germany), and 
transformed into E.coli XL1-Blue cells. ERK1/2 cDNA was a kind gift of Dr. Morten Frödin, 
Biotech Research & Innovation Centre). All constructs were verified by DNA sequencing of 
the PCR-generated inserts. GenBank accession numbers: NM_000218 for hKv7.1, 
NM_00219 for hKCNE1, and U29332 for hFHL2. 
b) RT-PCR 
Total RNA from human left or right atria and left or right ventricle (Ambion, TX, 
USA) were used as templates. The RNA was reverse transcribed using a poly T primer (5’-
T24–V-N-3’) and SuperscriptTM III according to the manufacturer's instructions (Invitrogen, 
CA, USA). Controls were performed in the absence of template. The RT products were PCR 
amplified using PfuUltraII polymerase (Stratagene) and oligodeoxynucleotides primers for 
human FHL2 and GAPDH (FHL2-forward: 5’-cctgcgaggagtgtgggaagcc-3’; FHL2-reverse: 
5’-tctcatagcagggcacacag-3’; GAPDH-forward: 5’-cacccatggcaaattccatg-3’; GAPDH-reverse: 
5’-catgagtccttccacgatac-3’). The cycling conditions were 2 min at 94ºC; 25 cycles at 94ºC for 
30 s, annealing temperature (differing between primer pairs, depending on the melting 
temperature Tm of the primers) for 40 s, 72ºC for 30 s; 72ºC for 5 min. Amplified products 
were analyzed using 2% agarose gels. The PCR products were sequenced for identity 
confirmation. 
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c) In vitro transcription 
The cRNAs were prepared from linearized expression constructs of Kv7.1 wild-type 
or mutants, KCNE1 wild-type or mutants, and FHL2 in pGEM-HE using the Ambion T7 m-
Message Machine kit according to the manufacturer’s instructions (Ambion). RNA 
concentrations were determined by UV spectroscopy, integrity was confirmed by gel 
electrophoresis. cRNA were stored at -80°C until injection. 
2) Yeast Two-Hybrid Screening 
A yeast two-hybrid screening of a human heart cDNA library (Clontech) was 
performed with the cytoplasmic N-terminus of human Kv7.1 as bait. Initially, the bait was 
tested for auto-activation of the reporters’ genes HIS and MEL in the yeast strain S. cerevisiae 
AH109 and found suitable for a yeast two-hybrid screen. Transformation into the yeast strain 
S. cerevisiae AH109 was performed according to the manufacturer’s instructions 
(MATCHMAKER GAL4 Two-Hybrid System 3, Clontech). Briefly, co-transformants were 
first plated onto synthetic dropout medium (DO:TL) lacking tryptophan and leucine to select 
for colonies containing both hybrid plasmids and then transferred onto dropout medium 
DO:TLHA that also lacked histidine and adenine to select for protein-protein interactions. 
Media were supplemented with 6 mM 3-amino-1,2,4-triazole to suppress background growth 
of the yeast strain. Isolated colonies were re-streaked onto DO:TLHA plates containing 5-
Bromo-4-chloro-3-indoyl-α-D-galactopyranoside (X-α-Gal). Blue colonies were re-streaked 
onto DO:TL medium/X-α-Gal to allow for segregation of discrete prey cDNAs that could be 
expressed in the first selection. Positive clones were re-streaked on DO:TLHA/X-α-Gal, 
resulting blue colonies were used to inoculate liquid DO:TL medium. A total of 6,2×106 
clones was screened. 
Yeast expression plasmids were isolated by means of lycitase solution (Sigma, 
Denmark) and the purified yeast plasmid DNA was transformed into LEU deficient E.coli 
KC8 cells by electroporation and plated on M9/amp medium to select for the prey plasmid. 
Several colonies were used to inoculate LB/amp medium, plasmid DNA was prepared and 
the plasmids sequenced. 
3) Immunohistochemistry 
a) Isolation of guinea pig cells 
Ventricular cardiomyocytes were isolated as described previously (Hansen et al., 
2006). In brief, perfusion velocity was 10 to 15 ml/min for all solutions, and all solutions 
were heated at 37°C and filtered before use. Guinea pigs were anesthetized with 
intraperitoneal injection of pentobarbital (50–75 mg/kg). In addition, 1 ml/kg heparin (1000 
IU/ml) was injected in vena femoralis. Respiration was maintained by artificial ventilation 
through a cannula in the trachea (volume, 12 ml/kg; rate, 60 strokes/min). Upon thoracotomy, 
a perfusion cannula was inserted and fixed in aorta for retrograde perfusion in a simplified 
Langendorff setup. The heart was surgically removed from the thorax and perfused for 5 min 
with oxygenated (100% O2) Tyrode’s solution (with Ca
2+) consisting of (in mM) 135 NaCl, 4 
KCl, 1 MgCl2, 0.33 NaH2PO4, 10 HEPES, 10 glucose, and 2 CaCl2, pH 7.4 with NaOH. This 
was followed by 5-min perfusion with oxygenated (100% O2) Tyrode’s solution without 
Ca2+. Perfusion was continued for 5 min with an oxygenated potassium gluconate solution 
consisting of (in mM) 120 potassium gluconate, 20 NaCl, 1 mM MgCl2, 10 HEPES, and 10 
glucose, pH 7.4 with KOH. Finally, enzymatic digestion was performed by perfusion with 
oxygenated (100% O2) potassium gluconate solution containing 0.5 mg/ml collagenase (type 
CLS-2; Medinova Scientific A/S, Denmark) and 50 mM CaCl2. Ventricular muscles were 
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minced with scissors and dispersed with gentle agitation in oxygenated (100% O2) potassium 
gluconate buffer containing collagenase and CaCl2. After filtering and harvesting, cells were 
gently resuspended in potassium gluconate solution without collagenase and CaCl2. Cells 
were stored at room temperature until use. 
b) Imaging 
Incubation with primary antibodies in PBS with 0.2% fish skin gelatin was performed 
overnight at 4°C (FHL2, goat polyclonal IgG, Santa Cruz 1:100, hKv7.1 C-20, goat 
polyclonal IgG, Santa Cruz 1:100, or hKv7.1-CT rabbit polyclonal IgG as described 
previously 1:100 (Calloe et al., 2007). After washing, the cells were incubated with 
secondary antibodies (AlexaFluor 568, Donkey Anti-Goat IgG, Mol. Probes, 1:800, DαR, 
AlexaFluor 488, Donkey Anti-Rabbit IgG Mol. Probes, 1:200) for 2 h at room temperature. 
The stained cells were washed and subsequently mounted in Prolong antifade (Molecular 
Probes). Images were obtained using a Leica TCS SP2 confocal microscope equipped with a 
63xNA1.2 objective and an argon and HeNe laser. 
4) Electrophysiology 
a) Oocytes isolation and injection 
Female Xenopus laevis frogs were anaesthetized for 15–20 min in 2 g/L Tricain (3-
aminobenzoic acid ethyl ester, Sigma A-5040) before an ovarian lobe was removed from the 
abdominal cavity through a small insertion. Oocytes were defolliculated enzymatically by 
incubation in 1% collagenase (Boehringer Mannheim, 1088831) and 0.1% trypsin inhibitor 
(Sigma T-2011) in Kulori medium (90 mM NaCl, 1 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 
and 5 mM Hepes, pH 7.4) for 1 h followed by five washes in Kulori containing 0.1% BSA 
(Sigma A-6003), and incubation for 1 h in a hypertonic phosphate buffer (100 mM K2HPO4, 
pH 6.5). Subsequently, stages V and VI oocytes were selected, and kept in Kulori medium for 
24 h at 19ºC before injection of 50 nl cRNA. cRNA was injected using a Nanoject 
microinjector (Drummond Scientific, Broomall, PA). Oocytes were kept at 19ºC in Kulori 
medium for 1–4 days before measurements were performed. 
Currents were recorded from oocytes injected with Kv7.1 (WT or S66D), KCNE1 
(WT or D76N or S74L) with or without FHL2. The different cRNA were co-injected in a 1:1 
molar ratio. 
b) Two-electrode voltage clamp recordings 
Currents were recorded at room temperature three days after injection using a two-
electrode voltage-clamp amplifier (CA-1B, Dagan, Minneapolis, MN) and PULSE 
acquisition software (HEKA, Lambrecht, Germany). Oocytes were bathed in Kulori medium 
(90 mM NaCl, 4 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 5 mM HEPES, pH 7.4) and subject to 
a constant flow of Kulori medium during recordings. Electrodes were pulled from 
borosilicate glass capillaries on a horizontal patch electrode puller and had a tip resistance 
between 0.3 and 2.0 MΩ when filled with 2 M KCl. The protocol used to obtain the current-
voltage relationships was as follow: the oocytes were held at -80 mV, then voltages ranging 
from -100 mV to +60 mV were applied with 20 mV increment and finally the oocytes were 
hyperpolarized to -120 mV. 
c) FHL2 protein injection 
Oocytes were injected with cRNAs encoding Kv7.1/KCNE1 or Kv7.1/KCNE1-D76N, 
as mentioned above. Currents were elicited by repetitive pulsing to +60mV. Recombinant 
GST-tagged full length FHL2 protein (Abnova ; no: H00002274-P01) was injected into 
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oocytes during continuous recording. Current amplitude was assessed at the end of polarising 
pulses. The injection was performed using a nanoliter injector 2000 (WPI). 
d) Data analysis 
All data was analyzed using IGOR software and values shown are mean ± SEM. The 
number of independent experiments is indicated by n. Comparison of the biophysical 
properties of Kv7.1 with or without KCNE1 and with or without FHL2 was performed using 
an unpaired t-test. Data was considered significant at P<0.05. 
 
The animal care procedures used in this study followed the guidelines of the Danish 
National Committee for Animal Studies. 
 
C – Results 
A yeast two-hybrid screening of a human heart cDNA library (Clontech Laboratories 
Inc.) was performed with the cytoplasmic N-terminus (NT, amino-acids 2-121) of human 
Kv7.1. A total of 83 positive clones was identified, 3 of which encoded a full-length cDNA of 
four-and-a-half LIM domain protein 2 (FHL2). To confirm the specificity of the interaction 
between hKv7.1-NT and hFHL2, constructs containing the GAL4-DNA activating domain 
(AD) fused with full-length hFHL2 were co-transformed with either the GAL4-binding 
domain (BD) fused with hKv7.1-NT or hKv7.1 C-terminus (CT) in yeast strains AH109 or 
CG1945, respectively (figure 1A). Moreover, the GAL4-binding domain alone was co-
expressed with the FHL2 construct. The previously described interaction of the Kv7.1-CT (aa 
354-676) with calmodulin (Shamgar et al., 2006) was used as positive control (C+). Growth 
was only detected when the Kv7.1-NT was co-transformed with FHL2. It has been reported 
earlier that the β-subunit KCNE1 binds to FHL2 and that this interaction is necessary to 
generate  the IKs current (Krishnamurthy et al., 2004; Kupershmidt et al., 2002). However, we 
were not able to reproduce the interaction between FHL2 and the C-terminus part of KCNE1 
previously described by Kupershmidt and colleagues (Kupershmidt et al., 2002) due to 
persistent auto-activation of the KCNE1 fusion constructs in our experiments. 
In order to delineate the interaction interface, we mapped the essential binding 
domains of hKv7.1 and hFHL2 (figure 1B). Full-length FHL2 was required to activate the 
HIS reporter gene in yeast, as constructs carrying various deletions of LIM domains were 
unable to do so. This indicates that all LIM domains are necessary for the interaction with the 
Kv7.1-NT. In addition, the full-length hKv7.1-NT was necessary for interaction (data not 
shown). 
 
[Figure 1 near here] 
 
We approached FHL2 mRNA expression in the different cardiac compartments by 
RT-PCR analysis of human left and right atria, and left and right ventricles (figure 2A). We 
found FHL2 expressed in all compartments of the heart investigated with a lower expression 
level in left atria when compared to the housekeeping gene GAPDH (Glyceraldehyde-3-
phosphate dehydrogenase) (Barber et al., 2005). Furthermore, we performed 
immunolocalization studies on guinea pigs cardiomyocytes (figure 2B). FHL2 and Kv7.1 co-
localize in the same subcellular structures resembling T-tubules, yet with a restricted overlap 
in expression pattern. 
 
[Figure 2 near here] 
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We then investigated whether Kv7.1 or IKs (Kv7.1/KCNE1) currents were affected by 
FHL2. In order to avoid any expression system differences, we recorded currents from 
oocytes, as well as from mammalian cells (HEK293 and CHO-K1). The graphs in figure 3A 
show representative current traces elicited by a voltage step protocol (see Materials and 
Methods) applied on oocytes injected with Kv7.1 with or without FHL2. Expression of the 
Kv7.1 α-subunit alone gave rise to slowly activating, almost non-inactivating and slowly 
deactivating voltage-dependent K+ currents. Upon co-injection with FHL2, no changes in 
amplitude or in activation parameters, as visualized in figure 3A (right panel), were observed. 
We then performed similar experiments in CHO-K1 and HEK293 cells to assure the presence 
of mammalian-specific signalling pathways, not present in frog oocytes. However, we could 
not see any FHL2 effect on Kv7.1 currents in mammalian cells either (data not shown). 
Next, we co-injected KCNE1 cRNA with Kv7.1 in oocytes to reconstitute the IKs 
current. Co-expression with the β-subunit changed the biophysical properties of the Kv7.1 
channel, as expected: slower activation, increase in current amplitude, as well as loss of 
inactivation (Fig. 3B) (Barhanin et al., 1996; Sanguinetti et al., 1996). As for Kv7.1, co-
expression of FHL2 with IKs did not affect the currents. 
 
[Figure 3 near here] 
 
Earlier studies, showing that some mutations associated with LQT syndrome could 
reveal different types of intracellular regulation of the IKs complex (Kurokawa et al., 2003) 
and that FHL2 interacts with the C-terminus of the β-subunit KCNE1 (Kupershmidt et al., 
2002), encouraged us to investigate the effect of FHL2 on previously reported dysfunctional 
IKs channel complexes mutated in the KCNE1 gene. We concentrated our work on two LQT5 
mutant channels that carry mutations located in the cytoplasmic C-terminus region of 
KCNE1, namely D76N and S74L (Splawski et al., 1997). Hence, we co-expressed Kv7.1 with 
KCNE1-D76N or KCNE1-S74L in the absence or presence of FHL2 (figure 4A). 
Intriguingly, the current resulting from the expression of Kv7.1 and KCNE1-D76N, that 
failed to induce detectable currents (Splawski et al., 1997), was rescued by co-injection with 
FHL2 (figure 4A, left panel). The rescuing effect of FHL2 was also observed with the other 
LQT5 mutant (S74L), but to a less pronounced extend (figure 4A, right panel). 
Next, we sought to analyse the time scale of the FHL2 rescue. We would expect a fast 
recovery in the case of a direct effect of the FHL2 protein on the IKs complex, whereas a 
delayed effect would occur in the case of a co-transcriptional or co-translational-mediated 
mechanism. Injection of about 15 pg of purified FHL2 protein in oocytes expressing Kv7.1 
and KCNE1-D76N during continuous recording showed a fast onset of current increase. This 
was not seen in oocytes injected with Kv7.1 and KCNE1-WT (figure 4B, left panel). 
Furthermore, the increase of current amplitude in the mutant IKs complex was persistent after 
13 minutes of recordings (figure 4B, right panel). 
In order to address whether Kv7.1-NT was involved in the rescuing effect of FHL2, 
we made recordings from oocytes co-injected with a N-terminus-truncated version of the 
channel (short Kv7.1) (Schmitt et al., 2000) and KCNE1-D76N, with or without FHL2. 
Deleting the N-terminus of the α-subunit abolished the rescue of mutated IKs channel 
complex by FHL2, indicating that the Kv7.1-NT is essential for FHL2 mediated recovery of 
IKs currents. 
 
[Figure 4 near here] 
 
Since we observed i) an interaction in the yeast two-hybrid system, ii) a partial co-
localization in immunofluorescense experiments and iii) a clear functional effect of FHL2 on 
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mutated IKs channels, we searched for a possible linker between FHL2 and the Kv7.1-NT, as 
the yeast two-hybrid system does not rule out intermediary partners between the two proteins. 
FHL2 has been reported to interact with the mitogen-activated (MAP) kinase ERK2 
(Extracellular signal-Regulated Kinase 2) and to negatively interfere with signal-induced 
nuclear accumulation of ERK2 (Purcell et al., 2004). This MAP kinase pathway has also 
been implicated in hypertrophic growth response in the cardiomyocytes and in the intact heart 
(for review see Johannessen et al., 2006). Moreover, Kong and co-workers have shown that 
FHL2 modifies the hypertrophic response of the heart to β-adrenergic stimulation (Kong et 
al., 2001). 
Hence, we analyzed the Kv7.1-NT for possible consensus sites for ERK1/2 kinase 
phosphorylation. Indeed we found one consensus site at amino-acids 64-67 (PXS/TP) (figure 
5A). Comparing amino-acid sequences from human, mouse and rat, the site appears to be 
evolutionary conserved. We first tested whether the ERK1/2 inhibitor PD98059 had an effect 
on CHO-K1 cells transfected with Kv7.1 channels. Application of the inhibitor at various 
concentrations did not have any effect on the currents (data not shown). This absence of 
effect could be due either to an absence of Kv7.1 sensitivity to ERK1/2 or to a low 
endogenous level of the kinase in CHO-K1 cells. To test the latter hypothesis we co-
expressed a constitutively active form of ERK1/2 with Kv7.1. However, Kv7.1 currents were 
not affected by mimicking an increase in the kinase activity (data not shown). 
To address whether manipulating the putative ERK1/2 consensus site would have an 
effect on the IKs current rather than on the α-subunit alone, we generated a Kv7.1 mutant 
mimicking the phosphorylation of the channel by ERK1/2 by replacing the serine (S) at 
position 66 with an aspartic acid (D). Interestingly, the Kv7.1-S66D mutant, when co-injected 
with KCNE1-D76N prevents FHL2 rescue of the current. 
 
[Figure 5 near here] 
 
D –Discussion 
In this study we identified FHL2 as a partner of Kv7.1, the α-subunits of the slow 
repolarizing current IKs in the heart. We also show that the interaction is conferred through 
the cytoplasmic amino-terminal part of the channel protein. Immunohistochemistry studies in 
guinea pig cardiomyocytes revealed a co-localization of the two proteins in the T-tubules. 
Despite the lack of effects of FHL2 on Kv7.1 or IKs wild-type currents, our experiments 
showed a dramatic functional effect of FHL2 on the IKs β-subunit’s disease-associated 
mutants D76N and S74L. In summary, our data show that FHL2 forms a macromolecular 
complex with the components of the IKs channel. We, furthermore, provide evidence that the 
effect of FHL2 is modulated by an ERK1/2 phosphorylation site located in the Kv7.1-NT. 
 
FHL2 has been previously reported to interact with the IKs channel (Kupershmidt et 
al., 2002). In this study, the C-terminal part of KCNE1 was shown to interact with all four-
and-a-half LIM domains of FHL2 and that FHL2 was required to generate the IKs current in 
heterologeous system (Kupershmidt et al., 2002). Lower IKs current levels in HEK293 cells 
were suggested to be due to the lack of endogenous FHL2 expression. In our study, we could 
not reproduce KCNE1 interaction with FHL2, due to persistent auto-activation of the KCNE1 
fusion constructs. Furthermore we did not see any difference in the endogenous expression 
levels of FHL2 in the tested cell lines (HEK293 and CHO-K1, data not shown); in addition 
the Kv7.1/IKs current levels were similar with or without co-transfection of FHL2 in all 
expression systems tested. Commercially available cell lines, despite derived from the same 
clone, are evolving over time (shape, protein expression, properties in general) (Thomas & 
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Smart, 2005). It is possible that the cell lines used by Kupershmidt and co-workers miss or 
have additional proteins than the cell lines used in our experiments, leading to different 
experimental results. Intriguingly, it has been shown that in COS-1 cells, FHL2 expression 
was highest 32 hours after transfection and then rapidly declined, which may indicate a high 
turnover of this protein and transient functional effects (Scholl et al., 2000). Everything 
considered, the discrepancies in the results might point out to a more complicated regulation 
of the IKs current in which not all the involved partners have been identified yet. 
 
FHL2, also known as DRAL/Slim3 is a 32 kDa protein expressed predominantly in 
human heart and to a lesser extent in skeletal muscle, testis, prostate epithelium and human 
brain (Chan et al., 1998; Genini et al., 1997; Tanahashi & Tabira, 2000). Several functions 
have been attributed to FHL2; the protein has been proposed to play a role in regulation of 
gene expression, cell adhesion, cell survival, and signal transduction (for review see 
Johannessen et al., 2006). Most of these proposed functions came from yeast two-hybrid 
screening approaches in which the interaction partners isolated suggested the function of 
FHL2. Furthermore, posttranslational modifications of the FHL2 protein itself were proposed 
to contribute to these different functions as some interactions are conferred through the 
different LIM domains in a specific way (El Mourabit et al., 2003). 
In this study, we demonstrated that FHL2 interacts with the N-terminal part of Kv7.1 
channels and that all four-and-a-half LIM domains are necessary for the interaction. In 
addition we co-localized FHL2 and Kv7.1 proteins in T-tubules of guinea pig (and rat, data 
not shown) cardiomyocytes. FHL2 has previously been localized in cytoplasm, nucleus, and 
focal contacts of different cell lines. In cardiac myofibrils, an additional prominent 
localization to the Z-discs and to a lesser extent to the M-bands was reported (Scholl et al., 
2000). The different localizations may imply different interaction partners at specific areas 
within the cells. In a refined study, Lange and co-workers showed a localization of FHL2 to 
the N2B (periphery of the Z-lines) and is2 (M-band) regions of the giant protein titin, where 
it acts as an adaptor protein (Lange et al., 2002). Titin is also interacting with telethonin/T-
cap (Gregorio et al., 1998) which has been shown to associate with KCNE1 (Furukawa et al., 
2001). T-cap and KCNE1 are localized at the Z-line in isolated cardiac myofibrils. Furukawa 
and coworkers investigated the localization of the KCNE1 protein within different regions of 
the heart and detected protein expression only in the inner ventricular myocardium, but not in 
outer myocardium, and only diffusely distributed in the atrium. Also the Kv7.1 protein was 
detected in both the peripheral sarcolemma and in T-tubules of adult rat heart (Rasmussen et 
al., 2004), increasing the likelihood of a Kv7.1/KCNE1/FHL2 macromolecular complex. 
 
We identified ERK1/2 as an additional player in the Kv7.1/KCNE1/FHL2 complex, 
since the effect of FHL2 on mutant IKs complexes was modulated by a ERK1/2 
phosphorylation site located in the Kv7.1-NT. ERK1/2 (Extracellular signal-Regulated Kinase 
1/2), also called MAPK3 (Mitogen-Activated Protein Kinase 3), is a serine/threonine protein 
kinase and is part of one of the three major MAP Kinase signaling cascades (ERK, p38 and 
JNK) (Qi & Elion, 2005). In cardiomyocytes, the signaling cascade is initiated by G-protein-
coupled receptors such as angiotensin II or adrenergic receptors (for review see Wang, 2007). 
It has been shown earlier that the ERK1/2 kinase interacts with FHL2 (Purcell et al., 
2004). Stimulation with phorbol 12-myristate 13-acetate (PMA) to induce kinase 
phosphorylation, enhanced the interaction of the two proteins, both in exogenous expression 
systems and in endogenous proteins from rodent cardiac cell extract or cultured neonatal 
cardiomyocytes. Additionally, by addressing the subcellular localization of the kinase, 
Purcell and co-workers reported that a major pool of ERK1/2 and FHL2 were co-localized to 
the Z-lines in both adult and neonatal cardiomyocytes. On the functional level it could be 
Paper 2: FHL2 and MAPK3 are Involved in the Regulation of the IKs Current in the Heart 
__________________________________________________________________________________________ 
______________________________________________________________________________________ 
Nathalie Hélix Nielsen PhD thesis  
36 
shown that the adapter protein exerted a negative effect on the kinase activity in 
cardiomyocytes by affecting the translocation of the kinase from the cytosol to the nucleus 
(Purcell et al., 2004). Similarly, FHL2 was proven to interact with another kinase, namely the 
sphingosine kinase-1 (SK1), and to impair its action by confining the localization of SK1 to 
the cytoplasm (the kinase being active when localized close to the plasma membrane) (Sun et 
al., 2006). In the light of previous work and our findings we suggest that FHL2 is a central 
adapter in complex formation of ion channel subunits and regulatory proteins like kinases. 
 
Interestingly enough, the Kv7.1-NT does not only harbor a consensus site for 
phosphorylation by ERK1/2, it also contains a so-called docking site characterized by an LxL 
motif (position 38-40). It has been suggested that kinase binding to docking sites lead to an 
increase in local enzyme concentration and subsequently an increase in substrate 
phosphorylation (Karin, 1995; Sharrocks et al., 2000). In addition, docking domains may 
help recruiting kinases into signaling complexes (for review see Sharrocks et al., 2000). 
Interestingly, our group has earlier shown that this di-leucine motif is important for correct 
localization of Kv7.1 channels in epithelial cells and that mutation of these residues led to a 
protein accumulation in endosomal compartments (Jespersen et al., 2004). Further studies are 
needed to elucidate the precise mechanisms by which FHL2, in concert with ERK1/2, 
regulates the IKs channel. 
A clue about the physiological relevance might come from FHL2 knockout studies 
(Chu et al., 2000a). FHL2 knockout mice are viable and have normal cardiovascular 
development (Chu et al., 2000a), most likely resulting from the redundancy with other LIM-
only family members that are also expressed in the heart, such as FHL1 and FHL3 (Chu et 
al., 2000b). Intriguingly, FHL1 was recently reported to interact with the potassium channel 
Kv1.5 and to be essential for the reconstitution of the ultra rapid repolarization current in the 
atria, IKur (Yang et al., 2008). Despite their normal cardiovascular development, FHL2 knock 
out mice show a hypertrophic response following β-adrenergic stimulation (Kong et al., 
2001). This implies that FHL2 may be involved in stress-induced remodeling mechanisms 
and that it interacts with downstream effectors of β-adrenergic receptor (β-AR) signaling, as 
suggested by Kong and colleagues (Kong et al., 2001). Interestingly, the IKs current is 
essential during β-AR stimulation. Its activation promotes action potential shortening and an 
increase in heart rate (Volders et al., 2003). In animal models of ventricular hypertrophy, 
downregulation of the repolarizing current IKs and dampened β-adrenergic activation have 
been linked to proarrhythmia (Stengl et al., 2006). Though genetic inhibition of cardiac 
ERK1/2 did not appear to mediate hypertrophic response, the long-term absence of this 
pathway predisposed the myocardium to cell death (Purcell et al., 2007). However, the 
mechanisms of the ERK1/2 protection have not been elucidated yet. 
 
Both subunits of the IKs channel complex appear to interact with FHL2 (Kupershmidt 
et al., 2002 and this study). Moreover, Lin and colleagues recently showed that the N-
terminal part of the Kv11.1 (HERG) channel interact with FHL2 (Lin et al., 2008). In their 
studies, co-expression of FHL2 increased Kv11.1 current amplitudes and led to a faster 
deactivation of the current in mammalian cells. Intriguingly, KCNE1 has been reported to 
interact with Kv11.1 resulting in an increase in current amplitude (Bianchi et al., 1999; 
McDonald et al., 1997). Yet the interaction of Kv11.1 and KCNE1 is a matter of debate as the 
mechanism of current augmentation remains unknown. Another open question in the field 
resides in several conflicting reports about a direct interaction of Kv7.1 and Kv11.1 channels 
(Ehrlich et al., 2004; Grunnet et al., 2005). In a study addressing the subcellular localization 
of Kv7.1 and Kv11.1 protein in rat myocytes, the proteins were detected as discretely 
localized clusters in the cell membrane with slightly differential subcellular distribution in the 
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T-tubules (Rasmussen et al., 2004). It is conceivable that the same protein (FHL2) could 
interact with the channels alternately dependent on e.g. extracellular signals, metabolic or 
developmental states. It is tempting to propose that these reports each reflect single snapshots 
of a macromolecular complex that is highly regulated by a variety of signalling pathways. 
The molecular mechanisms of the temporal and spatial formation of this complex involved in 
cardiac excitability remain elusive. 
 
In summary, we identified new partners of the Kv7.1/KCNE1 ion channel complex. 
We demonstrated that FHL2 interacts with the N-terminal part of Kv7.1. The functional effect 
of FHL2 could only be seen in LQT5-induced mutations as the LIM-only protein rescued the 
KCNE1 mutated channels D76N and S74L. Furthermore ERK1/2 phosphorylation of Kv7.1 
in the N-terminus is modulating the FHL2 rescue. 
In our attempt to understand the development of arrhythmia at a molecular level, it is 
of utmost importance to take into consideration the diverse protein composition and the 
different types of regulation of the ion channel complexes. This is particularly important 
because many disease mutations cause amino-acid substitutions in regions of the protein 
where their direct functional consequences are not immediately obvious. 
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F – Figures 
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Figure 1: FHL2 binds to Kv7.1-NT in the yeast two-hybrid system. A) Detection of 
Kv7.1 binding to FHL2. Binding was assayed by HIS3/MEL induction in the GAL4 based 
yeast two-hybrid system (strain S. cerevisiae AH109). C+: interaction of calmodulin with 
Kv7.1-CT (Shamgar et al., 2006), serves as positive control; C-: FHL2-AD (Activation 
Domain) construct expressed alone, negative control; NT: cotranformation of FHL2 with 
Kv7.1-NT; CT: cotranformation of FHL2 with Kv7.1-CT, BD: cotranformation of FHL2 with 
empty binding domain vector. B) Detection of Kv7.1-NT binding to full-length but not 
truncated FHL2 constructs. Double determination of growth on selective medium is shown as 
assayed by HIS3 induction (experiments in B are performed in yeast strain CG1945). 
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Figure 2: Kv7.1 and FHL2 are both present in the heart and co-localize to T-tubules. 
A) RT-PCR analysis of mRNA expression of FHL2 in left/right atria (LA, RA) and left/right 
ventricle (LV, RV) of human heart (expected fragment length 350 bp) related to mRNA 
GAPDH expression (expected fragment length 372 bp); B: brain, C: water control,∗: 500 bp 
DNA mass marker. Note the weak band present in the brain lane. B) Subcellular localization 
of endogenous Kv7.1 and FHL2 proteins in guinea pig cardiomyocytes. Isolated ventricular 
cells were incubated with FHL2 (left) or Kv7.1 (middle) antibodies. The overlay picture 
(right) shows that the proteins are present the similar T-tubular structures. 
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Figure 3: FHL2 does not affect Kv7.1 and IKs currents. A) Xenopus laevis oocytes 
were injected with Kv7.1 with or without FHL2 (left and central panels). A voltage protocol 
(upper panel) was applied to the oocytes. The current-voltage relationship was obtained by 
plotting the current at the end of each step as a function of the voltage (right panel). B) 
Oocytes were injected with Kv7.1 and KCNE1 with or without FHL2 (left and central 
panels). The same voltage protocol was used and the same analyses were performed, as in A 
(right panel). Data are shown as mean ± SEM with n as the number of experiments. 
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Figure 4: FHL2 rescues D76N and S74L KCNE1 mutant channels, the effect being 
dependent of Kv7.1-NT. A) Normalized current voltage-relationships obtained from oocytes 
co-injected with Kv7.1 and KCNE1-D76N (left panel) with or without FHL2 or Kv7.1 and 
KCNE1-S74L (right panel) with or without FHL2. The voltage protocol is the same as in 
figure 3. B) Left panel: Currents recorded before and after injection of FHL2 protein in 
oocytes expressing Kv7.1 and KCNE1 (WT or D76N). Right panel: Normalized currents at 
the end of the +60 mV pulse were analyzed and plotted over time. Through an injection 
pipette about 15 pg purified FHL2-protein was injected into the oocyte during continuous 
recording. C) Current-voltage relationship recorded from oocytes injected with the short 
version of Kv7.1 and KCNE1-D76N with or without FHL2. Data are shown as mean ± SEM 
with n as the number of experiments. 
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Figure 5: Involvement of ERK1/2 in FHL2 rescue of KCNE1-D76N. A) Alignment of 
the proposed ERK1/2 consensus site in Kv7.1-NT. B) Normalized current-voltage 
relationships obtained from oocytes injected with Kv7.1/KCNE1-D76N with and without 
FHL2 (left panel) and Kv7.1-S66D/KCNE1-D76N with and without FHL2 (right panel). The 
voltage protocol is the same as in figure 3. Data are shown as mean ± SEM with n as the 
number of experiments. 
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